产品
编 号：F086584
分子式：C25H29FN4O4
分子量：468.52
分子式：C25H29FN4O4
分子量：468.52
产品类型
规格
价格
是否有货
结构图
CAS No: 1239269-51-2
产品详情
生物活性：
Henatinib is an orally active small-molecule multikinase inhibitor that has demonstrated broad and potent antitumor activities. Henatinib inhibits the activity of VEGFR-2, c-kit, PDGFR with IC50 values of 0.6 nM, 3.3 nM and 41.5 nM, respectively. Henatinib significantly inhibits VEGFR-2 phosphorylation and its downstream signal pathway in human umbilical vein endothelial cells (HUVECs).
体外研究：
Henatinib shows high binding affinities for VEGFRs, PDGFR and stem cell factor receptor.Henatinib significantly inhibits VEGFR-2 phosphorylation and its downstream signal pathway in human umbilical vein endothelial cells (HUVECs), and consistently inhibited VEGF-stimulated HUVEC proliferation, migration and tubule formation.
Henatinib is an orally active small-molecule multikinase inhibitor that has demonstrated broad and potent antitumor activities. Henatinib inhibits the activity of VEGFR-2, c-kit, PDGFR with IC50 values of 0.6 nM, 3.3 nM and 41.5 nM, respectively. Henatinib significantly inhibits VEGFR-2 phosphorylation and its downstream signal pathway in human umbilical vein endothelial cells (HUVECs).
体外研究：
Henatinib shows high binding affinities for VEGFRs, PDGFR and stem cell factor receptor.Henatinib significantly inhibits VEGFR-2 phosphorylation and its downstream signal pathway in human umbilical vein endothelial cells (HUVECs), and consistently inhibited VEGF-stimulated HUVEC proliferation, migration and tubule formation.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备